Apoptosis in prostate cancer: bax correlation with stage

Area of Science:

• Oncology
• Molecular Biology
• Cell Death Research

Background:

• Apoptosis dysregulation is linked to prostate tumorigenesis by affecting cell death rates.
• Bcl-2 (anti-apoptotic) and Bax (pro-apoptotic) are key regulators of apoptosis.
• Investigating these markers in prostate cancer is crucial for understanding disease progression.

Purpose of the Study:

• To investigate apoptosis and its regulatory molecular markers, Bcl-2 and Bax, in Iranian prostate cancer patients.
• To correlate apoptosis indices with proliferation markers and clinical parameters.
• To assess the prognostic value of Bax expression in prostate cancer.

Main Methods:

• Immunohistochemistry was used to examine Bcl-2, Bax, and Ki-67 expression in 50 prostate carcinoma tissue samples.
• The TUNEL method was employed to detect apoptotic cells.
• Correlations between apoptotic/proliferation indices, protein expression, and clinicopathological features (stage, grade, Gleason score) were analyzed.

Main Results:

• Apoptosis was observed in 12% of prostate cancers, with no correlation to differentiation status.
• Bcl-2 expression correlated significantly with the Ki-67 proliferation index (r = 0.349, P = 0.012).
• High Bax expression showed a significant correlation with cancer stage (r = 0.388, P = 0.031) but not apoptosis index.

Conclusions:

• Prostate cancer patients in this study exhibited a distinct apoptosis positivity pattern compared to previous reports.
• Bax protein expression emerged as a potential useful marker for predicting prostate cancer prognosis.
• Further research may elucidate the role of non-functional Bax or other pro-apoptotic molecules.